10-Q: Chicago Atlantic BDC Reports Strong Q3 Growth Post-Acquisition

Chicago Atlantic BDC, Inc. reports substantial growth in investment income and net assets for Q3 2025, driven by its strategic Loan Portfolio Acquisition.

Summary

• Total investment portfolio fair value increased to $311.4 million as of September 30, 2025, up from $275.2 million at December 31, 2024, primarily due to the $219.6 million Loan Portfolio Acquisition completed on October 1, 2024.
• Net investment income for the three months ended September 30, 2025, surged to $9.5 million, a significant increase from $14.5 thousand in the prior year period.
• For the nine months ended September 30, 2025, net investment income reached $24.8 million, compared to $1.5 million for the same period in 2024.
• Net assets resulting from operations increased to $8.8 million for the three months ended September 30, 2025, reversing a net decrease of $0.2 million in the prior year period.
• Net Asset Value (NAV) per share rose to $13.27 as of September 30, 2025, from $13.20 at December 31, 2024.
• The company entered into a $100 million senior secured revolving credit agreement on February 11, 2025, with $11 million outstanding and $89 million available as of September 30, 2025.
• The Adviser voluntarily waived $1.3 million of operating expenses for the nine months ended September 30, 2025, under an expense limitation agreement.
• The portfolio remains heavily concentrated in the cannabis industry, representing 75.5% of fair value as of September 30, 2025.
• 99.2% of loan investments were rated Grade 2 (performing in-line with expectations) and 0.8% were Grade 3 (performing below expectations) as of September 30, 2025, a slight shift from 100% Grade 2 at December 31, 2024.
• No loans were on non-accrual status as of September 30, 2025, or December 31, 2024.

Sentiment

Score: 8

Explanation: The company demonstrates strong financial performance with significant increases in investment income, net investment income, and net assets, largely driven by a successful strategic acquisition. The establishment of a new credit facility provides ample liquidity. While there's a slight deterioration in portfolio quality and a market discount to NAV, the overall growth trajectory and proactive expense management are positive.

Positives

• Substantial growth in total investment income, reaching $15.1 million for Q3 2025 and $40.1 million for the nine months ended September 30, 2025, indicating strong revenue generation.
• Significant increase in net investment income to $9.5 million for Q3 2025 and $24.8 million for the nine months, demonstrating improved profitability.
• Positive net increase in net assets resulting from operations of $8.8 million for Q3 2025, a strong turnaround from a loss in the prior year.
• NAV per share increased to $13.27, reflecting overall asset growth and improved financial health.
• Successful integration of the $219.6 million Loan Portfolio Acquisition, significantly expanding the investment base.
• Establishment of a $100 million Revolving Line of Credit provides substantial liquidity and financing flexibility, with $89 million still available.
• The Adviser waived $1.3 million in operating expenses for the nine months, contributing to lower net expenses.
• Non-qualifying assets decreased significantly to 4.36% of total assets from 19.14%, indicating better compliance with BDC regulations.

Negatives

• Cash and cash equivalents decreased to $10.5 million from $23.9 million, indicating significant cash deployment for investments and other activities.
• Total liabilities increased to $24.3 million from $8.4 million, primarily due to the new revolving line of credit and increased distributions payable.
• A slight deterioration in portfolio asset quality, with 0.8% of investments moving to Grade 3 (performing below expectations) from 100% Grade 2 in the prior period.
• The company's common stock trades at a significant discount to NAV, with a closing sales price of $10.04 per share on November 12, 2025, representing a 24.34% discount to the $13.27 NAV per share.

Risks

• The cannabis industry is highly speculative and subject to legality issues under U.S. federal law, posing a risk to portfolio companies' business plans and loan recovery.
• Changes in U.S. Presidential Administration or Department of Justice policies regarding federal cannabis laws could negatively impact portfolio companies.
• U.S. federal courts may not enforce contracts related to cannabis businesses, even if legal under state law.
• Assets collateralizing cannabis loans may be forfeited to the U.S. federal government in enforcement actions.
• Potential for increased U.S. Food and Drug Administration regulation of cannabis could negatively affect the industry.
• Difficulty for cannabis businesses to obtain necessary insurance policies, exposing them to additional risks and liabilities.
• Significant opposition from other industries (pharmaceutical, adult beverage, tobacco) with powerful lobbying resources could adversely affect the cannabis industry.
• Challenges for cannabis companies to access traditional banking services due to federal uncertainties.
• Difficulty in obtaining financing for investment strategies in the regulated cannabis industry.
• Evolving and broad laws and regulations affecting the cannabis industry may restrict operations or require additional regulatory approvals.
• Concentration risk with three portfolio companies representing 34.2% of the fair value of the portfolio, and the largest representing 16.9%.
• Credit risk of default or non-performance by portfolio companies, especially those with below investment grade ratings.
• Liquidity risk due to illiquid or thinly traded securities in the portfolio, making sales difficult or at substantial discounts.
• Interest rate risk, where rising interest rates could increase borrowing costs and reduce net investment income.
• Prepayment risk, where favorable market conditions could lead to early loan prepayments, potentially reducing achievable yields if capital cannot be reinvested at similar rates.
• Risks associated with possible disruption in operations or the economy due to terrorism, natural disasters, conflicts (Russia-Ukraine, Middle East), and volatility in energy/commodity prices.
• Impact of information technology system failures, data security breaches, data privacy compliance, network disruptions, and cybersecurity attacks.
• Risks related to the use of leverage and credit facilities, including potential foreclosure on assets if obligations are defaulted upon.

Future Outlook

The company intends to continue its strategy of investing primarily in secured debt, unsecured debt, equity warrants, and direct equity investments in privately held businesses, with a focus on highly complex and regulated industries, particularly the cannabis ecosystem. It expects to leverage its Revolving Line of Credit and proceeds from investment income and portfolio turnover to finance future investment objectives. The company aims to maintain its RIC tax treatment by distributing at least 90% of its investment company taxable income annually.

Management Comments

• Peter Sack, Chief Executive Officer, certified that the Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made not misleading, and that the financial statements fairly present the financial condition, results of operations, and cash flows.
• Thomas Geoffroy, Interim Chief Financial Officer, provided a similar certification regarding the accuracy and fair presentation of the financial information in the Quarterly Report.

Industry Context

The company operates as a specialty finance provider, primarily targeting the cannabis industry, which is characterized by high complexity and regulation, leading to an underserved capital market. This niche allows for potentially attractive pricing and favorable loan terms. However, the industry faces significant legal and regulatory uncertainties at the U.S. federal level, impacting banking, insurance, and potential government enforcement actions. The company also diversifies into growth & technology, esoteric & asset-based lending, and liquidity solutions, seeking strong cash flow profiles and low leverage in these areas.

Management Changes

Corporate Governance

Related Party Transactions

• Investment Advisory Agreement: Fees payable to the Adviser include a base management fee (1.75% of gross assets) and an incentive fee (20% of Pre-Incentive Fee Net Investment Income, subject to a hurdle, and 20% of realized capital gains).
• Expense Limitation Agreement: The Adviser waived $1,338,202 of operating expenses for the nine months ended September 30, 2025, under this agreement.
• Administration Agreement: The company reimburses the Adviser for costs and expenses incurred in performing administrative obligations, including sub-administrator fees and an allocable portion of CFO/CCO compensation.
• License Agreement: The company has a nonexclusive, royalty-free license to use the 'Chicago Atlantic' name as long as the Adviser or an affiliate remains the investment adviser.
• Affiliated Loan Administrative and Collateral Agent: Chicago Atlantic Admin, LLC (a wholly-owned subsidiary of Chicago Atlantic Group, LP) serves as loan administrator and collateral agent for certain loans, handling collections and disbursements.
• Co-Investments: The company may co-invest with other investment vehicles managed by its affiliates, in accordance with an exemptive order and allocation policies.
• Adviser as Seed Investor: The Adviser provided initial funding by purchasing approximately 4.5 million shares in the IPO and may sell or distribute these shares in the future, potentially affecting market prices.

Stakeholder Impact

• Shareholders: Benefit from increased net investment income and NAV per share, and consistent quarterly dividends. However, the stock trades at a discount to NAV, and potential future sales by the Adviser could impact market price. Dividend reinvestment plan allows for compounding of shares.
• Portfolio Companies: Access to capital in underserved, complex, and highly regulated industries, particularly cannabis, enabling growth and strategic initiatives.
• Creditors (Revolving Line of Credit lenders): Loans are secured by a significant portion of the company's investment portfolio, providing collateral protection.
• Adviser: Receives increased management and incentive fees due to asset growth and strong performance, while also providing expense waivers and administrative services.

Next Steps

• The Board approved a cash dividend of $0.34 per share payable on January 15, 2026, to stockholders of record on December 31, 2025.
• The company will continue to manage its investment portfolio, focusing on its four sub-strategies: Cannabis, Growth & Technology, Esoteric & Asset-Based Lending, and Liquidity Solutions.
• Ongoing monitoring and management of the Revolving Line of Credit, which has an availability termination date of February 11, 2027, and a scheduled maturity date of March 31, 2028.
• The Expense Limitation Agreement with the Adviser is in effect through September 30, 2025, after which its terms may be re-evaluated or renewed.

Key Dates

Recommendation

The company has demonstrated strong growth in investment income and net assets following a significant acquisition, indicating a robust business model in its niche markets. The establishment of a new credit facility provides financial flexibility. However, the stock currently trades at a substantial discount to its Net Asset Value, which suggests the market has not fully priced in the recent growth or is factoring in the inherent risks of its concentrated cannabis portfolio. While the operational performance is positive, the discount to NAV and the specific industry risks warrant a 'hold' recommendation for seasoned investors, allowing for further observation of sustained performance and potential narrowing of the NAV discount, rather than an immediate 'buy' or 'sell' based solely on this report.

Keywords

BDC, Business Development Company, Cannabis Investment, Secured Debt, Loan Portfolio Acquisition, Investment Income, Net Asset Value, Revolving Credit Facility, Specialty Finance, Private Credit, Alternative Lending, SEC Filing, 10-Q